Brand names you'll see in India — the cheat sheet

Ozempic. Rybelsus. Wegovy. Mounjaro. Saxenda. Trulicity. What each is and which conditions they're approved for.

Semaglutide brands

Ozempic (injectable, 0.5 / 1.0 / 2.0 mg) — diabetes indication. Wegovy (injectable, up to 2.4 mg) — weight management. Rybelsus (oral tablets, 3 / 7 / 14 mg) — diabetes. All Novo Nordisk.

Tirzepatide brand

Mounjaro (injectable, 2.5–15 mg). One molecule, approved for diabetes in India. Zepbound (same molecule under weight-management label) is approved in the US but not yet here under that name.

Liraglutide brands

Victoza (diabetes) and Saxenda (weight) — older once-daily semaglutide cousin. Less potent than the newer molecules but well-established.

Dulaglutide brand

Trulicity. Once-weekly diabetes drug; modest weight effect compared to semaglutide or tirzepatide.